Home › NDC Lookup › RxCUI directory › RxCUI 2262026

Amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule — RxCUI 2262026

RxNorm drug concept · Semantic clinical drug
RxCUI 2262026 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2262026
Official nameAmoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)6,073 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amoxicillin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amoxicillin treats bacterial infections — things like ear infections, strep throat, sinus infections, certain respiratory infections, skin infections, and urinary tract infections....
  • What kinds of infections does amoxicillin actually treat?
  • Yes — absolutely finish the full course. Feeling better doesn't mean all the bacteria are gone. If you stop early, any remaining bacteria can rebound, and they may be harder to tre...
  • Do I have to take the whole course even if I feel better after a few days?
📖 Read our full Amoxicillin guide →

🕸️ Concept Web — How Amoxicillin 250 MG / omeprazole 10 MG / rifabuti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule RxCUI 2262026

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Amoxicillin 723
    • Omeprazole 7646
    • Rifabutin 55672
    • Amoxicillin / omeprazole / rifabutin 2262025
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Talicia 2262027
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amoxicillin / omeprazole / rifabutin Delayed Release Oral Capsule 2262024
    • Amoxicillin / omeprazole / rifabutin Oral Product 2262022
    • Amoxicillin / omeprazole / rifabutin Pill 2262023
    • Amoxicillin / omeprazole / rifabutin Delayed Release Oral Capsule [Talicia] 2262029
    • Talicia Oral Product 2262030
    • Talicia Pill 2262031
    • Delayed Release Oral Capsule 316995
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amoxicillin 250 MG SCDC · 315369
  • Omeprazole 10 MG SCDC · 316407
  • Rifabutin 12.5 MG SCDC · 2262021
  • Amoxicillin / omeprazole / rifabutin Delayed Release Oral Capsule SCDF · 2262024
  • Amoxicillin / omeprazole / rifabutin Oral Product SCDG · 2262022
  • Amoxicillin / omeprazole / rifabutin Pill SCDG · 2262023

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2262026 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
57841-1150-02 2 BOTTLE in 1 CARTON (57841-1150-2) / 84 CAPSULE, DELAYED R... Talicia RedHill Biopharma Ltd 2020-03-09
57841-1150-04 2 BOTTLE in 1 CARTON (57841-1150-4) / 84 CAPSULE, DELAYED R... Talicia RedHill Biopharma Ltd 2021-09-24
Observed labelers: RedHill Biopharma Ltd (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$4.8834
Range $4.8834–$4.8834 · middle 50% $4.8834–$4.8834 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.